Drilldown: Medicines

Phentermine (1)

Adipex-P, Lomaira (low-dose); with topiramate as Qsymia (1)

[[:Category:Anorectics|Anorectic (appetite suppressant)]] (1) · [[:Category:Schedule_IV_controlled_substances|Schedule IV controlled substance]] (1) · [[:Category:Sympathomimetics|Sympathomimetic]] (1)

None (1)

'"`UNIQ--vote-0000129E-QINU`"' (1)

15-37.5 mg PO once daily before breakfast or 1-2 hours after; Lomaira 8 mg TID (1)

15, 30, 37.5 mg capsules/tablets; 8 mg Lomaira (1)

None · Indication-specific · 40 mg/d · 10 mg/d · 20 mg/d · 80 mg/d · 10 mg/d (adults) · 100 mg/d · 4 g/d · 400 mg/d · 40 mg/d typical; up to 240 mg/d for Zollinger-Ellison · 5 mg/d · 50 mg/d · 600 mg/d · No fixed ceiling; titrate to clinical effect and tolerability with CDC opioid prescribing guidance constraints on morphine-milligram-equivalent (MME) totals · No fixed maximum; titrated to TSH target · TID per eye · Titrated to glucose; no fixed ceiling · Titrated to glucose; no fixed maximum · '''20 mg/day in adults >60 years''' per FDA's 2011-2012 QT-prolongation warning; 40 mg/day in adults ≤60

Other values:

Search

Oral (1)

None · Hours · 30-60 minutes · 1-2 hours · ~30 min · LDL lowering at 2 weeks, max by 4 weeks · ~1 hour · 15-30 minutes · 15–30 min · 1–2 h · 30–60 min · Antidepressant effect emerges over 1-2 weeks · BP and symptomatic LUTS improvement within 1-2 weeks · BP effect within 1-2 weeks · Clinical improvement within 24-72 hours · Days · Motor improvement over days at therapeutic dose · Over weeks · Postprandial glucose effect within days; HbA1c by 12 weeks · Sleep effect from first dose; antidepressant effect over 1-4 weeks

Other values:

Search

~12-14 hours (1)

~25 hours'"`UNIQ--ref-0000129F-QINU`"' (1)

High (oral)'"`UNIQ--ref-000012A0-QINU`"' (1)

Contraindicated in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)

None (1)